DaVita
DVA
#1913
Rank
โ‚น944.96 B
Marketcap
โ‚น15,023
Share price
3.00%
Change (1 day)
46.85%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): โ‚น1,299

According to DaVita's latest financial reports the company's current EPS (TTM) is โ‚น1,295. In 2025 the company made an earnings per share (EPS) of โ‚น944.15 a decrease over its 2024 EPS that were of โ‚น1,029.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,29937.64%
2025โ‚น944.15-8.25%
2024โ‚น1,02944.94%
2023โ‚น709.9727.26%
2022โ‚น557.90-35.56%
2021โ‚น865.7844.1%
2020โ‚น600.8219.7%
2019โ‚น501.93540.48%
2018โ‚น78.37-76.07%
2017โ‚น327.47-19.31%
2016โ‚น405.83242.52%
2015โ‚น118.48-62.87%
2014โ‚น319.0713.43%
2013โ‚น281.288.45%
2012โ‚น259.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
โ‚น2,254 74.06%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,145-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
โ‚น3,238 150.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
โ‚น175.95-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA